» Articles » PMID: 39134712

An Explorative Analysis on the Optimal Cryo-passes and Freezing Time of the Ultrathin Cryoprobe in Endobronchial Ultrasound-guided Transbronchial Mediastinal Cryobiopsy

Overview
Journal Sci Rep
Specialty Science
Date 2024 Aug 12
PMID 39134712
Authors
Affiliations
Soon will be listed here.
Abstract

EBUS-guided transbronchial mediastinal cryobiopsy (TBMC) has emerged as a promising biopsy tool for diagnosing hilar and mediastinal pathologies. However, several fundamental technical aspects of TBMC remain unexplored. This study aims to determine the optimal number of cryo-passes and freezing time of the ultrathin cryoprobe in EBUS-TBMC concerning specimen size and procedural diagnostic yield. We conducted a retrospective chart review of patients with mediastinal and hilar lesions who underwent EBUS-TBMC between January 2021 and April 2023 across three hospitals in Malaysia. A total of 129 EBUS-TBMC procedures were successfully completed, achieving an overall diagnostic yield of 88.4%. Conclusive TBMC procedures were associated with larger specimen sizes (7.0 vs. 5.0 mm, p < 0.01). Specimen size demonstrated a positive correlation with diagnostic yield (p < 0.01), plateauing at specimen size of 4.1-6.0 mm. A significant positive correlation was also observed between the number of cryo-passes and both specimen size (p < 0.01) and diagnostic yield (p < 0.05). Diagnostic yield plateaued after 2-3 cryo-passes. In contrast, longer freezing times trended towards smaller specimens and lower diagnostic yield, though not reaching statistical significance. The highest diagnostic yield was recorded at the 3.1-4.0 s freezing time. The safety profile of TBMC remains favourable, with one case (0.8%) of pneumothorax and nine cases (7%) of self-limiting bleeding. In our cohort, TBMC performance with 2-3 cryo-passes and a 3.1-4.0 s freezing time to achieve a total aggregate specimen size of 4.1-6.0 mm appeared optimal. Further prospective studies are needed to validate these findings.

Citing Articles

Ultrasound-guided transbronchial cryobiopsy of mediastinal and hilar lesions: a multicenter pragmatic cohort study with real-world evidence.

Mangold M, Franzen D, Hetzel J, Latshang T, Roeder M, Vesenbeckh S BMJ Open Respir Res. 2024; 11(1.

PMID: 39668107 PMC: 11647314. DOI: 10.1136/bmjresp-2024-002617.


Reply to Lee : Endovascular Forceps Biopsy of Pulmonary Artery Intimal Sarcoma: A Safer Approach.

Petrarulo S, Ravaglia C, De Grauw A, Oldani S, Paul S, Dubini A Am J Respir Crit Care Med. 2024; 211(2):288-289.

PMID: 39586104 PMC: 11812551. DOI: 10.1164/rccm.202410-1948LE.

References
1.
Abuqayyas S, Raju S, Bartholomew J, Abu Hweij R, Mehta A . Management of antithrombotic agents in patients undergoing flexible bronchoscopy. Eur Respir Rev. 2017; 26(145). PMC: 9488780. DOI: 10.1183/16000617.0001-2017. View

2.
Yarmus L, Semaan R, Arias S, Feller-Kopman D, Amador R, Bosmuller H . A Randomized Controlled Trial of a Novel Sheath Cryoprobe for Bronchoscopic Lung Biopsy in a Porcine Model. Chest. 2016; 150(2):329-36. DOI: 10.1016/j.chest.2016.01.018. View

3.
Tang Y, Tian S, Chen H, Li X, Pu X, Zhang X . Transbronchial lung cryobiopsy for peripheral pulmonary lesions. A narrative review. Pulmonology. 2023; 30(5):475-484. DOI: 10.1016/j.pulmoe.2023.08.010. View

4.
Ariza-Prota M, Perez-Pallares J, Fernandez-Fernandez A, Garcia-Alfonso L, Cascon J, Torres-Rivas H . Endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy in the diagnosis of mediastinal lesions: safety, feasibility and diagnostic yield - experience in 50 cases. ERJ Open Res. 2023; 9(2). PMC: 10107076. DOI: 10.1183/23120541.00448-2022. View

5.
Hetzel J, Maldonado F, Ravaglia C, Wells A, Colby T, Tomassetti S . Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure. Respiration. 2018; 95(3):188-200. DOI: 10.1159/000484055. View